Sun J, Zhang W
Heliyon. 2024; 10(2):e24575.
PMID: 38304844
PMC: 10830578.
DOI: 10.1016/j.heliyon.2024.e24575.
Lai C, He N, Zeng J, Long C, Shi M, Li J
J Cancer. 2023; 14(16):3117-3129.
PMID: 37859826
PMC: 10583587.
DOI: 10.7150/jca.87792.
Li Y, Gu S, Li X, Huang Q
Medicine (Baltimore). 2023; 102(37):e35080.
PMID: 37713834
PMC: 10508432.
DOI: 10.1097/MD.0000000000035080.
Wang Z, Yuan Q, Chen X, Luo F, Shi X, Guo F
Funct Integr Genomics. 2023; 23(3):263.
PMID: 37540295
PMC: 10403435.
DOI: 10.1007/s10142-023-01158-1.
Qi M, Sun L, Zheng L, Zhang J, Han Y, Wu F
Front Mol Neurosci. 2022; 15:972615.
PMID: 36311014
PMC: 9597691.
DOI: 10.3389/fnmol.2022.972615.
In Silico Prediction of the Bioactive Profile and Metabolites of in Diseases Related to the Excessive Production of Interleukin-6.
Ezaouine A, Salam M, Nouadi B, Anachad O, Messal M, Chegdani F
Bioinform Biol Insights. 2022; 16:11779322221115665.
PMID: 35958296
PMC: 9358202.
DOI: 10.1177/11779322221115665.
LncRNA B4GALT1-AS1 promotes non-small cell lung cancer cell growth via increasing ZEB1 level by sponging miR-144-3p.
Liu S, Yang P, Li F, Dou R, Liu J, Liu G
Transl Cancer Res. 2022; 11(3):538-547.
PMID: 35402178
PMC: 8990218.
DOI: 10.21037/tcr-22-296.
Upregulation of miR-144-3p expression attenuates glioma cell viability and invasion by targeting BCL6.
Zhou J, Liu R
Exp Ther Med. 2021; 22(4):1157.
PMID: 34504602
PMC: 8393981.
DOI: 10.3892/etm.2021.10591.
The Emerging Role of miRNAs for the Radiation Treatment of Pancreatic Cancer.
Nguyen L, Schilling D, Dobiasch S, Raulefs S, Santiago Franco M, Buschmann D
Cancers (Basel). 2020; 12(12).
PMID: 33317198
PMC: 7763922.
DOI: 10.3390/cancers12123703.
A Novel miRNA Restores the Chemosensitivity of AML Cells Through Targeting FosB.
Wang H, Zhan H, Jiang X, Jin L, Zhao T, Xie S
Front Med (Lausanne). 2020; 7:582923.
PMID: 33123543
PMC: 7573296.
DOI: 10.3389/fmed.2020.582923.
MicroRNA-144: A novel biological marker and potential therapeutic target in human solid cancers.
Zhou M, Wu Y, Li H, Zha X
J Cancer. 2020; 11(22):6716-6726.
PMID: 33046994
PMC: 7545670.
DOI: 10.7150/jca.46293.
microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma.
Zheng Q, Zhu Q, Li C, Hao S, Li J, Yu X
Clinics (Sao Paulo). 2020; 75:e1804.
PMID: 32844953
PMC: 7426600.
DOI: 10.6061/clinics/2020/e1804.
Characterization of lncRNA-Associated ceRNA Network to Reveal Potential Prognostic Biomarkers in Lung Adenocarcinoma.
Wang Y, He R, Ma L
Front Bioeng Biotechnol. 2020; 8:266.
PMID: 32426332
PMC: 7212445.
DOI: 10.3389/fbioe.2020.00266.
MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers.
Kooshkaki O, Rezaei Z, Rahmati M, Vahedi P, Derakhshani A, Brunetti O
Int J Mol Sci. 2020; 21(7).
PMID: 32276343
PMC: 7177921.
DOI: 10.3390/ijms21072578.
miR-144-3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt/β-catenin signaling.
Sun N, Zhang L, Zhang C, Yuan Y
Cell Mol Biol Lett. 2020; 25:19.
PMID: 32206063
PMC: 7079415.
DOI: 10.1186/s11658-020-00210-3.
CircZDHHC20 represses the proliferation, migration and invasion in trophoblast cells by miR-144/GRHL2 axis.
Zhou B, Zhang X, Li T, Xie R, Zhou J, Luo Y
Cancer Cell Int. 2020; 20:19.
PMID: 31956297
PMC: 6958575.
DOI: 10.1186/s12935-020-1097-2.
CeRNA Expression Profiling Identifies KIT-Related circRNA-miRNA-mRNA Networks in Gastrointestinal Stromal Tumour.
Jia N, Tong H, Zhang Y, Katayama H, Wang Y, Lu W
Front Genet. 2019; 10:825.
PMID: 31552107
PMC: 6746987.
DOI: 10.3389/fgene.2019.00825.
Targeting acquired oncogenic burden in resilient pancreatic cancer: a novel benefit from marine polyphenols.
Aravindan S, Somasundaram D, Somasundaram S, Natarajan M, Herman T, Aravindan N
Mol Cell Biochem. 2019; 460(1-2):175-193.
PMID: 31367889
PMC: 8895420.
DOI: 10.1007/s11010-019-03579-8.
Expression of activator protein-1 in papillary thyroid carcinoma and its clinical significance.
Xiao C, Huang Y, Gao Q, Feng Z, Li Q, Liu Z
World J Surg Oncol. 2019; 17(1):25.
PMID: 30704487
PMC: 6357454.
DOI: 10.1186/s12957-019-1568-x.
miR-144-5p Enhances the Radiosensitivity of Non-Small-Cell Lung Cancer Cells via Targeting ATF2.
Song L, Peng L, Hua S, Li X, Ma L, Jie J
Biomed Res Int. 2018; 2018:5109497.
PMID: 29850528
PMC: 5925000.
DOI: 10.1155/2018/5109497.